Natalia Georgantzoglou

Dr. Natalia Georgantzoglou

University of Athens, Medical school
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Natalia GeorgantzoglouNatalia Georgantzoglou
Natalia Georgantzoglou
APAlexandros Pergaris
Alexandros Pergaris
CMChristos Masaoutis
Christos Masaoutis
Stamatios TheocharisStamatios Theocharis
Stamatios Theocharis
Exosomes are extracellular vesicles, enriched in biomolecular cargo consisting of nucleic acids, proteins, and lipids, which take part in intercellular communication and play a crucial role in both physiologic functions and oncogenesis. Bladder cancer is the most common urinary malignancy and its incidence is steadily rising in developed countries. Despite the high five-year survival in patients diagnosed at early disease stage, survival substantially drops in patients with muscle-invasive or metastatic disease. Therefore, early detection of primary disease as well as recurrence is of paramount importance. The role that exosomal biomarkers could play in bladder cancer patient diagnosis and surveillance, as well as their potential therapeutic applications, has not been extensively studied in this malignancy. In the present review, we summarize all relevant data obtained so far from cell lines, animal models, and patient biofluids and tissues. Current literature suggests that urine is a rich source of extracellular vesicle-derived biomarkers, compared with blood and bladder tissue samples, with potential applications in bladder cancer management. Further studies improving sample collection procedures and optimizing purification and analytical methods should augment bladder cancer diagnostic, prognostic, and therapeutic input of extracellular vesicles biomarkers in the future.

14 July 2021 in Rheumatology
Verified
Journal Article
Closed access
PDF file
DPDimitris Anastasios Palamidas
Dimitris Anastasios Palamidas
OAOurania D Argyropoulou
Ourania D Argyropoulou
Natalia GeorgantzoglouNatalia Georgantzoglou
Natalia Georgantzoglou
EKElli Karatza
Elli Karatza
EXEvangelia Xingi
Evangelia Xingi
ATAthanasios G. Tzioufas
Athanasios G. Tzioufas
To explore the presence of neutrophil extracellular traps (NETs) in inflamed temporal artery biopsies (TABs) of patients with GCA. Ten patients with GCA [five with limited and five with associated generalized vascular involvement, as defined by 18F-fluorodeoxyglucose PET with CT (PET/CT)] and eight with PMR were studied. The presence, location, quantitation and decoration of NETs with IL-6, IL-1β and IL-17A were assessed in TABs at the time of disease diagnosis by tissue immunofluorescence and confocal microscopy. Paired serum levels of IL-6 and IL-17A were also evaluated in all patients. All temporal artery biopsies from GCA, but not PMR, patients had NETs located mainly in the adventitia, adjacent to the vasa vasorum. NETs decorated with IL-6 were present in 8/10 TABs of GCA patients, of whom 5 were PET/CT(+) and 3 PET/CT(–) patients. IL-17A(+) NETs were observed in all GCA patients. IL-1β(+) NETs were not detected in any GCA patient. No relation was found between serum IL-6 and IL-17A levels and NETs containing IL-6 and/or IL-17A. NETs bearing pro-inflammatory cytokines are present in inflamed GCA-TABs. Future studies with a larger number of patients from different centres will show whether the findings regarding neutrophils/NETs in the TAB are consistent and disclose their clinical impact.

9 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Natalia GeorgantzoglouNatalia Georgantzoglou
Natalia Georgantzoglou
SKStefania Kokkali
Stefania Kokkali
GTGerasimos Tsourouflis
Gerasimos Tsourouflis
Stamatios TheocharisStamatios Theocharis
Stamatios Theocharis
Adrenocortical carcinoma is a rare malignancy with aggressive behavior, with up to 40% of patients presenting with metastases at the time of diagnosis. Both conventional chemotherapeutic regimens and novel immunotherapeutic agents, many of which are currently being tested in ongoing clinical trials, have yielded modest results so far, bringing the need for a deeper understanding of adrenal cancer behavior to the forefront. In the recent years, the tumor microenvironment has emerged as a major determinant of cancer response to immunotherapy and an increasing number of studies on other solid tumors have focused on manipulating the microenvironment in the favor of the host and discovering new potential target molecules. In the present review we aim to explore the characteristics of adrenocortical cancer’s microenvironment, highlighting the mechanisms of immune evasion responsible for the modest immunotherapeutic results, and identify novel potential strategies.

29 March 2022 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
Natalia GeorgantzoglouNatalia Georgantzoglou
Natalia Georgantzoglou
DGDonald Green
Donald Green
KWKimberly N. Winnick
Kimberly N. Winnick
JSJanos Sumegi
Janos Sumegi
GCGregory W. Charville
Gregory W. Charville
KLKonstantinos Linos
Konstantinos Linos

12 July 2022 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
JSJustin T. Snow
Justin T. Snow
Natalia GeorgantzoglouNatalia Georgantzoglou
Natalia Georgantzoglou
DGDonald C. Green
Donald C. Green
OPOurania Parra
Ourania Parra
RLRobert LeBlanc
Robert LeBlanc
KLKonstantinos Linos
Konstantinos Linos

23 December 2022 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
Natalia GeorgantzoglouNatalia Georgantzoglou
Natalia Georgantzoglou
GSGuomiao Shen
Guomiao Shen
GJGeorge Jour
George Jour
KLKonstantinos Linos
Konstantinos Linos